Journal of Tumor Research

Journal of Tumor Research
Open Access

ISSN: 2684-1258

+44 1223 790975

Guochao Zhang

  • Research Article
    Clinicopathological and Prognostic Value of Programmed Death Ligand-1 (PD-L1) In Breast Cancer: A Meta-Analysis
    Author(s): Qi Xue and Guochao ZhangQi Xue and Guochao Zhang

    Background: The association of immunological checkpoint marker programmed death ligand-1 (PD-L1) and the prognosis of various malignancies has been widely observed, recently. However, the association between PD-L1 expression and breast cancer patients’ survival remains controversial. Thus, we performed this study to assess the clinical value of PD-L1. Methods: We searched the electronic databases for eligible literature. Medline/PubMed, EMBASE, the Cochrane Library databases and Grey literature were searched up to 30 March 2016 for the association between PD-L1 expression and breast cancer prognosis. Hazard ratios (HRs) for overall survival (OS) with 95% confidence intervals (CIs) according to the expression status of PD-L1 were calculated from the included studies. Moreover, the odds ratio (OR) was also analyzed to evaluate the associ.. View More»
    DOI: 10.35248/2684-1258.17.3.127

    Abstract PDF

Relevant Topics